Table 1.

Laboratory variables of control patients and AST–120-treated patients

	Control patients		AST–120-treated patients
	Baseline	After 3 months	Before treatment	After 3 months of treatment
Body weight (kg)	57.9 ± 11.7	57.2 ± 12.7	58.3 ± 11.1	57.9 ± 11.4
Fasting plasma glucose (mg/dL)	85.2 ± 6.4	83.8 ± 4.6	90.8 ± 4.0	89.8 ± 4.8
Systolic BP (mmHg)	126 ± 21	136 ± 8.4	123 ± 16	125 ± 29
Diastolic BP (mmHg)	68 ± 8.8	72 ± 11	74 ± 9.4	72 ± 9.2
BUN (mg/dL)	44.4 ± 18.5	49.1 ± 20.9	52.3 ± 18.3	49.6 ± 21.7
Serum creatinine (mg/dL)	4.5 ± 2.0	4.9 ± 2.0	4.4 ± 1.7	4.8 ± 1.9
Urinary protein excretion (g/day)	2.3 ± 1.7	3.0 ± 3.3	1.8 ± 1.5	1.5 ± 1.3a

^aP < 0.05 compared with the value before AST–120 treatment.